
Please try another search
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company’s products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland.
Name | Age | Since | Title |
---|---|---|---|
Steven V. Edelman | 67 | 2016 | Independent Non-Management Director |
Edward J. Fiorentino | 64 | 2015 | Independent Non-Management Director |
Douglas A. Roeder | 52 | 2015 | Independent Non-Management Director |
Douglas S. Prince | 69 | 2015 | Independent Non-Management Director |
Timothy T. Goodnow | 61 | 2015 | President, CEO & Director |
Stephen P. DeFalco | 61 | 2015 | Independent Chairman |
Francine Ratner Kaufman | 73 | 2019 | Chief Medical Officer & Director |
Koichiro Sato | 52 | 2023 | Director |
Sharon D. Larkin | 61 | 2021 | Independent Non-Management Director |
Brian B. Hansen | 57 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review